Theralase Technologies Inc. V.TLT

The confirmed power of TLT-1433.

[Maxcitrac]

In these 3 great articles provided by Eoganacht.

Steric hindrance, ligand ejection and associated photocytotoxic properties of ruthenium(II) polypyridyl complexes | JBIC Journal of Biological Inorganic Chemistry

Photodynamic therapy photosensitizers and photoactivated chemotherapeutics exhibit distinct bioenergetic profiles to impact ATP metabolism

Advances in the Design of Photoactivatable Metallodrugs: Excited State Metallomics - Shi - Angewandte Chemie International Edition - Wiley Online Library

18 Phd Scientists are acknowledging the power of TL-1433. And this list is getting bigger and bigger by the day.

What else do new investors need, to believe in Theralase incredible treatment.
What these 18 Phd scientists are saying is '' get your TLT shares before it is too late''.

[Sosak1]

How about this comment "Kevin Coombs, Professor, Medical Microbiology, University of Manitoba stated, "My team and I were excited by the results we have obtained as we have worked with several anti-viral compounds over the years and have found that Ruvidar is far more potent than any of the others we have worked with, in fact Ruvidar is effective at concentrations approximately 100-fold